Olema Pharmaceuticals Inc (OLMA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $662.30M
Last updated: Nov 17, 2026 at 4:15 PM ET
Olema Pharmaceuticals Inc (OLMA) Stock Chart
Olema Pharmaceuticals (OLMA) has a latest price of $7.22 on Nov 17, 2026, 80.1% below its 52-week high of $36.26. Its price fell 14.0% over the past 12 months. The month-end price fell 74.1% over the 5 years through Oct 2026, a compound annual decline of 23.7%.
Price Chart
From Nov 2020 to Oct 2026, its highest month-end close was $51.00 in Nov 2020 and its lowest $2.45 in Dec 2022, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart OLMA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for OLMA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 36.2%, and over 6 months it fell 44.9%. The month-end price fell 47.3% over the 3 years through Oct 2026, a compound annual decline of 19.2%.
| Period | Change |
|---|---|
| 1 month | +1.5% |
| 3 months | -36.2% |
| 6 months | -44.9% |
| 12 months | -14.0% |
| 12 months, with dividends | -14.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -47.3% | -19.2% |
| 5 years | -74.1% | -23.7% |
Price by Year
Its best calendar year was 2023, when the price rose 472.7%, and its weakest was 2021, when it fell 80.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $7.00 | -72.0% |
| 2025 | $25.00 | +328.8% |
| 2024 | $5.83 | -58.4% |
| 2023 | $14.03 | +472.7% |
| 2022 | $2.45 | -73.8% |
| 2021 | $9.36 | -80.5% |
Trading Range
The price is 10.2% below its 50-day average of $8.04 and 44.0% below its 200-day average of $12.90.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $7.22 | |
| 52-week high | $36.26 | -80.1% |
| 52-week low | $6.24 | +15.7% |
| 50-day average | $8.04 | -10.2% |
| 200-day average | $12.90 | -44.0% |
Price Risk
Over 3 years, its largest fall from a peak was 82.1%.
| Measure | Value |
|---|---|
| 1-year beta | 1.43 |
| Largest fall, 1 year | -82.1% |
| Largest fall, 3 years | -82.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About OLMA
What is OLMA's 1-year price change?
Olema Pharmaceuticals's price fell 14.0% over the past 12 months. With dividends included, the 12-month total return was -14.0%.
What is OLMA's 5-year price change?
Olema Pharmaceuticals's month-end price fell 74.1% over the 5 years through Oct 2026, a compound annual decline of 23.7%. These figures leave out dividends.
What is OLMA's 52-week high and low?
Olema Pharmaceuticals's 52-week high is $36.26 and its 52-week low is $6.24. Its latest price of $7.22 on Nov 17, 2026 is 80.1% below the high.
What is OLMA's beta?
Olema Pharmaceuticals's 1-year beta against the S&P 500 is 1.43, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 82.1%.
Is the OLMA chart free?
Yes. Advanced Charting for OLMA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
OLMA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors